4//SEC Filing
QVT Associates GP LLC 4
Accession 0000899243-19-015895
CIK 0001679082other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 8:05 PM ET
Size
7.3 KB
Accession
0000899243-19-015895
Insider Transaction Report
Form 4
QVT Fund V LP
Director10% OwnerOther
Transactions
- Purchase
Common Shares, $0.000017727 par value per share
2019-06-04$8.25/sh+2,424,242$19,999,997→ 40,765,599 total(indirect: see fn)
QVT Associates GP LLC
Director10% OwnerOther
Transactions
- Purchase
Common Shares, $0.000017727 par value per share
2019-06-04$8.25/sh+2,424,242$19,999,997→ 40,765,599 total(indirect: see fn)
Footnotes (1)
- [F1]QVT Financial LP, its general partner, QVT Financial GP LLC, QVT Financial Investment Cayman Ltd. and QVT Associates GP LLC, the general partner of certain funds managed by QVT Financial LP (collectively, "QVT"), may be deemed to have beneficial ownership over the 40,765,599 Common Shares held by Roivant Sciences Ltd. ("Roivant") because, as shareholders of Roivant, QVT may be deemed to have dispositive power and, therefore, beneficial ownership, over the Common Shares held by Roivant by virtue of governance arrangements in Roivant's bye-laws. The filing of this statement shall not be deemed an admission that QVT is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. QVT expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
Documents
Issuer
Myovant Sciences Ltd.
CIK 0001679082
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001290166
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 8:05 PM ET
- Size
- 7.3 KB